DEF: BullFrog AI 2026 Annual Meeting Proxy Statement

BullFrog AI Holdings, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.

Summary

• The 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, at 10:00 a.m. Eastern Time.
• Stockholders of record as of April 20, 2026, are entitled to vote, with 18,530,865 shares of common stock outstanding.
• Proposal 1: Election of four directors (Vininder Singh, R. Donald Elsey, William Enright, and Jason D. Hanson).
• Proposal 2: Ratification of M&K CPAs, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The company is utilizing the 'Notice and Access' method to provide proxy materials electronically to reduce costs and environmental impact.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing for an annual meeting, reflecting standard corporate governance practices without significant strategic shifts or controversial proposals.

Positives

• The company has maintained a consistent board structure with experienced directors in the biotechnology and life sciences sectors.
• The company has successfully implemented a clawback policy in compliance with Nasdaq listing standards.
• The company is actively managing costs by utilizing the 'Notice and Access' method for proxy distribution.

Negatives

• The company continues to rely on a small board of directors, which may limit diverse perspectives.
• The company's executive compensation includes significant equity-based awards, which may lead to shareholder dilution.

Risks

• The company faces risks associated with the development of its AI technology and drug assets.
• The company is subject to risks related to its ability to secure future financing and maintain its Nasdaq listing.
• The company faces potential cybersecurity risks, which are overseen by the Audit Committee.

Future Outlook

The company intends to continue its focus on AI-driven drug development and maintaining compliance with Nasdaq listing standards, while seeking to optimize its capital structure and operational efficiency.

Management Comments

• The Board of Directors unanimously recommends that you vote FOR each of the proposals.
• We believe this process will provide you with a safe, convenient and efficient way to access your proxy materials and vote your shares.

Industry Context

StockSavvy.ai notes that BullFrog AI operates in the highly competitive AI-driven drug discovery sector, where maintaining strong corporate governance and transparent financial reporting is critical for attracting institutional investment and maintaining Nasdaq compliance.

Comparison to Industry Standards

• The company's board composition and committee structure align with standard practices for small-cap biotechnology firms listed on Nasdaq.
• The use of 'Notice and Access' for proxy materials is a standard cost-saving measure adopted by many publicly traded companies.

Corporate Governance

Stakeholder Impact

• Shareholders are requested to vote on director elections and auditor ratification.
• The virtual meeting format provides accessibility for shareholders regardless of location.

Next Steps

• Stockholders are encouraged to vote their shares via the Internet, telephone, or mail prior to the Annual Meeting.
• The company will hold its virtual Annual Meeting on June 11, 2026.

Key Dates

Keywords

BullFrog AI, BFRG, Proxy Statement, Annual Meeting, Biotechnology, Artificial Intelligence, Corporate Governance